Electrocardiographic signs of cardiac ischemia at rest and during exercise in patients with COPD traveling to 3,100 m: data from a randomized trial of acetazolamide
In lowlanders with moderate to severe COPD ascending to 3,100 m, no ECG-derived signs of cardiac ischemia emerged neither at rest nor post-exercise and this was not modified by preventive acetazolamide therapy.
Authors
- Silvia Ulrich (ORCID: https://orcid.org/0000-0002-5250-5022)
- Talant Sooronbaev (ORCID: https://orcid.org/0000-0002-5609-0944)
- Mona Lichtblau (ORCID: https://orcid.org/0000-0003-4485-1758)
- Aline Buergin
- Laura C. Mayer (ORCID: https://orcid.org/0009-0004-4949-8548)
- Michaël Furian (ORCID: https://orcid.org/0000-0002-8518-5029)
- Simon Schneider (ORCID: https://orcid.org/0000-0003-3635-0515)
- Konrad E. Bloch (ORCID: https://orcid.org/0000-0002-2377-7387)
- Maamed Mademilov (ORCID: https://orcid.org/0000-0001-8528-3115)
- M.O. Christen
Institutions
- University Hospital of Zurich (CH)
- National Center of Cardiology and Internal Medicine (KG)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-02-06
- DOI
- https://doi.org/10.3389/fcvm.2025.1524201
- Citations
- 1
- Primary Topic
- Heart Rate Variability and Autonomic Control
- Type
- article
- Field-Weighted Citation Impact
- 1.39